Data on potential risks of COVID-19 in psoriasis patients limited, but reassuring

For patients with psoriasis concerned about their outcome if infected with COVID-19, “there is no evidence to support stopping biologics or systemic agents.”

Identifying pancreatitis etiology may help prevent progression

Potential etiology of acute pancreatitis in 2020 includes genetic factors, drugs, and comorbidities.

Dr. Brian Mandell gives his take on ACR’s newest gout guideline

New guideline articulates a broad approach to treatment that needs to be tailored to individual patients.

Identify the dominant symptom in IBS

Many patients with irritable bowel syndrome don’t seek care. When they do, discuss time lines and triggers.

Identifying pancreatitis etiology may help prevent progression

Potential etiology of acute pancreatitis in 2020 includes genetic factors, drugs, and comorbidities.

Address root causes to manage NASH

Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression.

Reassuring rheumatic disease patients on value of bisphosphonates

Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.

Hepatocellular carcinoma shows risk factor shift

Demographics, obesity, and metabolic factors have emerged as main drivers of disease.

Address root causes to manage NASH

Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression.

Strategic approach mitigates impact of antidrug antibodies in patients with rheumatic diseases

Consider dose escalation and adding an immunomodulator to overcome the impact of antidrug antibodies in rheumatic disease patients.

Pages